Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

DNA Methylation Profiling of Sorted Cells from Myelofibrosis Patients reveals Aberrant Epigenetic Regulation of Immune Pathways and identifies Early MPN Driver Genes

Hans Carl Hasselbalch, MD PhD, Helene Myrtue Nielsen, Cand.scient, Fazila Asmar, MD, Christen Lykkegaard Andersen, MD, Lasse Sommer Kristensen, PhD, Kruse A Torben, Mads Thomassen, PhD, Thomas Stauffer Larsen, Vibe Skov, PhD, Caroline Riley, MD, Lise Lotte Hansen, PhD, Morten K. Jensen, MD, Ole Weis Bjerrum, MD, Vasu Punj, Kirsten Grønbæk, MD DMSc

Blood (2014) 124 (21): 4576.

https://doi.org/10.1182/blood.V124.21.4576.4576

Published: 2014

Journal Articles

Diagnostic Tumor Mirna Profiling Predicts Molecular Relapse in Mantle Cell Lymphoma Patients Prospectively Followed for Minimal Residual Disease. Results from the Nordic MCL2-3 Trials

Simon Husby, MD, Lone Bredo Pedersen, Ulrik Ralfkiær, PhD-student, Christian Garde, Sara Ek, Arne Kolstad, MD PhD, Mats Jerkeman, MD PhD, Anna Laurell, Riikka Räty, Anja Pedersen, Christer Sundström, Marja-Liisa Karjalainen-Lindsberg, Jan Delabie, MD PhD, Erik Clasen-Linde, MD, Christopher Workman, PhD, Christian H Geisler, Kirsten Grønbæk, MD DMSc

Blood (2014) 124 (21): 2994.

https://doi.org/10.1182/blood.V124.21.2994.2994

Published: 2014

Journal Articles

Plasma Microrna Predicts B-Cell Lymphoma up to 12 Months before Diagnosis – Data from the Danish Blood Donor Study

Steffen Jørgensen, MSc, Dorte Tholstrup, MD, Jakob Werner Hansen, MD, Homburg Mikkelsen Keld, MD PhD, Henrik Hjalgrim, MD PhD, Peter de Nully Brown, Christian Erikstrup, MD PhD, Mikkel Steen Petersen, MSc, PhD, Kaspar Rene Nielsen, MD, Erik Sørensen, MSc, PhD, Jesper Troelsen, MSc, PhD, Henrik Ullum, MD PhD, Kirsten Grønbæk, MD DMSc, Ole Birger Pedersen, MD PhD

Blood (2014) 124 (21): 708.

https://doi.org/10.1182/blood.V124.21.708.708

Published: 2014

Journal Articles

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

Fazila Asmar, MD, Christoffer Hother, MD, PhD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD PhD, Helene Myrtue Nielsen, MSc, Ralfkiaer Ulrik, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Elisabeth Ralfkiaer, MD, DMSc, Peter de Nully Brown, MD, Kirsten Grønbæk, MD, DMSc

Blood (2013) 122 (21): 83.

https://doi.org/10.1182/blood.V122.21.83.83

Published: 2013

Journal Articles

miRNA Profiling Predicts Survival and Identifies a Novel Putative Oncomir in Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy

Christoffer Hother, MD, Ditte Reker, Konstantions Dimopoulos, MD, Steen Knudsen, PhD, Thomas Jensen, Michael B. Møller, MD, DMSc, Peter De Nully Brown, Elisabeth Ralfkiaer, Prof., MD, DMSc, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 1548.

https://doi.org/10.1182/blood.V120.21.1548.1548

Published: 2012

Journal Articles

Allelic Methylation Levels of VTRNA2-1 Predict Outcome in Higher Risk MDS Patients Not Treated by Azacytidine.

Marianne B. Treppendahl, MD, Magnus Tobiasson, MD, Anni Aggerholm, PhD, Mohsen Karimi, PhD, Trine Silkjaer, MD, Lone S. Friis, MD, PhD, Mette K. Andersen, PhD, Lars Kjeldsen, MD, PhD, Mette S. Holm, MD, PhD, Eva Hellström-Lindberg, PhD, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 2394.

https://doi.org/10.1182/blood.V120.21.2394.2394

Published: 2012

Journal Articles

miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A , and MIR34B/C

Christoffer Hother, MD, Fazila Asmar, MD, Gorjan Kulosman, MD, Marianne B. Treppendahl, MD, Ditte Reker, Ulrik Ralfkiaer, MSc, Anja Pedersen, Michael B. Møller, MD, DMSc, Peter De Nully Brown, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 296.

https://doi.org/10.1182/blood.V120.21.296.296

Published: 2012

Journal Articles

MicroRNA Profiling in Low-Grade Ocular MALT and Diffuse Large B-Cell Lymphoma: A Role for MYC and NFKB1 Mediated Dysregulation of MicroRNA Expression in Aggressive Disease

Christoffer Hother, MD, Peter Kristian Rasmussen, MD, Tejal Joshi, PhD, Ditte Reker, Ulrik Ralfkiaer, MSc, Christopher Workman, PhD, Peter De Nully Brown, Steffen Heegaard, Prof. MD, Elisabeth Ralfkiaer, Prof., MD, DMSc, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 1600.

https://doi.org/10.1182/blood.V120.21.1600.1600

Published: 2012

Journal Articles

Lenalidomide, Bendamustine, and Rituximab As First-Line Therapy for Patients > 65 Years with Mantle Cell Lymphoma: Results From the Phase I Portion of the Nordic Lymphoma Group MCL4 (LENA-BERIT) Trial

Mats Jerkeman, MD PhD, Arne Kolstad, MD, PhD, Anna Laurell, Riikka Räty, Kirsten Grønbæk, MD, DMSc, Lone Bredo Pedersen, Christian H. Geisler, PhD, MD

Blood (2011) 118 (21): 2700.

https://doi.org/10.1182/blood.V118.21.2700.2700

Published: 2011

Journal Articles

Mir-130a-Mediated Downregulation of SMAD4 Contributes to Reduced Sensitivity to TGFβ Stimulation in Promyelocytic Cells,

Mattias Hager, Corinna Cavan Pedersen, Maria Torp Larsen, Mette Klarskov Andersen, MD, Christoffer Hother, MD, Kirsten Grønbæk, MD, DMSc, Hanne Jarmer, Niels Borregaard, Jack B Cowland

Blood (2011) 118 (21): 3383.

https://doi.org/10.1182/blood.V118.21.3383.3383

Published: 2011

Journal Articles

Allelic Methylation Levels of the Non-Coding RNA Gene VTRNA2-1 Located on Chromosome 5q31.1 Predict Outcome in AML,

Marianne B. Treppendahl, MD, Xiangning Qiu, MD, Alexandra Søgaard, MSc, Cecilie Nandrup-Bus, MSc, Christoffer Hother, MD, Mette Klarskov Andersen, MD, Lars Kjeldsen, MD, PhD, Lars Möllgård, MD, Eva Hellstrom-Lindberg, MD, PhD, Johan Jendholm, MSc, Bo T. Porse, PhD, Peter A. Jones, PhD, DSc, Gangning Liang, PhD, Kirsten Grønbæk, MD, DMSc

Blood (2011) 118 (21): 3450.

https://doi.org/10.1182/blood.V118.21.3450.3450

Published: 2011

Journal Articles

Different Subtypes of Difffuse Large B-Cell Lymphomas Identified Using Microarrays and Phenotyping.

Christian Bjorn Poulsen, MD., Rehannah Borup, Finn Cilius Nielsen, dr.med.sci, Niels Borregaard, dr.med. sci, Mads Hansen, dr.med.sci., Kirsten Gronbaek, MD, Elisabeth Ralfkiaer, dr.med.sci.

Blood (2004) 104 (11): 4293.

https://doi.org/10.1182/blood.V104.11.4293.4293

Published: 2004

NARROW

DNA Methylation Profiling of Sorted Cells from Myelofibrosis Patients reveals Aberrant Epigenetic Regulation of Immune Pathways and identifies Early MPN Driver Genes

Diagnostic Tumor Mirna Profiling Predicts Molecular Relapse in Mantle Cell Lymphoma Patients Prospectively Followed for Minimal Residual Disease. Results from the Nordic MCL2-3 Trials

Plasma Microrna Predicts B-Cell Lymphoma up to 12 Months before Diagnosis – Data from the Danish Blood Donor Study

Diffuse Large B-Cell Lymphoma With Combined TP53 mutation and MIR34A methylation: Another “double hit” Lymphoma With Very Poor Outcome?

miRNA Profiling Predicts Survival and Identifies a Novel Putative Oncomir in Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy

Allelic Methylation Levels of VTRNA2-1 Predict Outcome in Higher Risk MDS Patients Not Treated by Azacytidine.

miR34s in Normal and Malignant B-Cells: miR34A Plays a Dominant Role in Normal B-Cells, and aggressive Diffuse Large B-Cell Lymphoma Carry Combined Lesions of TP53, MIR34A , and MIR34B/C

MicroRNA Profiling in Low-Grade Ocular MALT and Diffuse Large B-Cell Lymphoma: A Role for MYC and NFKB1 Mediated Dysregulation of MicroRNA Expression in Aggressive Disease

Lenalidomide, Bendamustine, and Rituximab As First-Line Therapy for Patients > 65 Years with Mantle Cell Lymphoma: Results From the Phase I Portion of the Nordic Lymphoma Group MCL4 (LENA-BERIT) Trial

Mir-130a-Mediated Downregulation of SMAD4 Contributes to Reduced Sensitivity to TGFβ Stimulation in Promyelocytic Cells,

Allelic Methylation Levels of the Non-Coding RNA Gene VTRNA2-1 Located on Chromosome 5q31.1 Predict Outcome in AML,

Different Subtypes of Difffuse Large B-Cell Lymphomas Identified Using Microarrays and Phenotyping.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only